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Despite a history of purslane usage as a herbal treatment for dyslipidemia and hyperglycemia management, existing evidence from clinical trials is controversial. The aim for the current study was to evaluate the efficacy of purslane supplementation on lipid parameters and glycemic status in adult populations. A systematic review was conducted in PubMed, Scopus, ISI Web of Science, and Google Scholar up to January 15, 2018, searching for randomized controlled trials that assessed the impact of purslane on fasting blood glucose (FBG), triglycerides, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C).
Based on the detected heterogeneity between studies, a random-or fixed-effect (Bhatnagar, Wickramasinghe, Williams, Rayner, & Townsend, 2015) . Based on official reports published by the American Heart Association, CVD was responsible for almost 31% of total global deaths in 2013, and it is projected to grow more than 50% by 2030 (Lloyd-Jones et al., 2010) . Besides high morbidity and mortality, this class of noncommunicable diseases is also associated with a loss of quality of life and high costs (Bloom et al., 2012) . These facts underline the role of CVD as a common health care problem and emphasize the importance of identifying appropriate solutions for its prevention and treatment. Overall, CVD is caused by a combination of genetic and environmental factors like imbalanced diet, sedentary lifestyle, smoking, and social stress (Association, 2017; Bhatnagar et al., 2015) . Additionally, metabolic risk factors including hyperglycemia and dyslipidemia play a dominant role in the onset and progression of CVD (Fakhrzadeh & Tabatabaei-Malazy, 2012; Levitan, Song, Ford, & Liu, 2004) . Thus, CVD can be prevented through strategies that can beneficially regulate lipid profiles and glucose levels. In this regard, modern medicine is increasingly focusing on lifestyle modifications and pharmacological approaches (Alabousi et al., 2017; Doughty, Del Pilar, Audette, & Katz, 2017) . Nowadays, in parallel with the above-mentioned solutions, complementary medicine can offer novel, safe, and cost-effective options for regulating blood lipid profiles and plasma glucose levels (Asgary, Rafieian-Kopaei, Shamsi, Najafi, & Sahebkar, 2014; Cicero et al., 2017; Panahi et al., 2016; Pirro et al., 2016; . One form of these complementary medicines is the use of herbaceous plants, such as ginger, garlic, and purslane.
Purslane (Portulaca oleracea L.) is a genus of the Portulacaceae family, which is distributed all over the world (Iranshahy et al., 2017) . This grassy plant is native to Iran and is widely used as a potherb in many areas of Asia, Europe, and the Mediterranean region (Heidarzadeh, Farzanegi, Azarbayjani, & Daliri, 2013) . The leaves of purslane are rich in flavonoids, alkaloids, organic acids, and other biologically active compounds, including vitamins, minerals, sterols, and essential fatty acids, such as α-linolenic acid (Gong et al., 2009; Jin, Wang, Liu, Gou, & Chan, 2016; Shanker & Debnath, 2015) . Several therapeutic effects have been attributed to purslane including antiseptic, antispasmodic, diuretic, antibacterial, wound-healing, analgesic, anti-inflammatory, skeletal muscle relaxant, bronchodilator, antipyretic, and antiasthmatic activities (Iranshahy et al., 2017; Masoodi, Ahmad, Mir, Zargar, & Tabasum, 2011; Zhou et al., 2015) . Furthermore, in ancient medical practice, purslane was used for the treatment of various ailments such as fever, diarrhea, and skin, liver, kidney, and spleen diseases (Shanker & Debnath, 2015; Sultana & Rahman, 2013) . According to the findings of animal studies, purslane may also exert antihyperglycemic and antihyperlipidemic properties (Lan & Fu-er, 2003; Movahedian, Ghannadi, & Vashirnia, 2007) . There have been several human investigations regarding the effect of purslane on blood glucose and lipid metabolism; however, the findings are not fully conclusive. For example, one study reported that administration of purslane reduced the levels of serum lipids and glucose (Dehghan et al., 2016) , whereas another study found no significant changes in these biomarkers (Bedakhanian, Entezari, Ghanadian, Askari, & Maracy, 2017) .
To clarify these inconsistencies in the results of human trials, a systematic review and meta-analysis was conducted on published randomized controlled trials (RCTs) to provide a more precise estimate of the overall effects of purslane administration on lipid parameters and glycemic status.
2 | METHODS
| Review design and search strategy
The whole process of the present systematic review and meta-analysis including preparing, conducting, and reporting was according to the established guidelines for meta-analyses of RCTs (PRISMA), as far as possible. The protocol was also published in the international prospective register of systematic reviews database (PROSPERO) under the registration number CRD42018087340.
A comprehensive electronic search for pertinent published studies was performed using the following databases from inception up to January 15, 2018, without any filter or restriction: PubMed, Scopus, ISI Web of Science, and Google Scholar. The search process was conducted by using a combination of two categories of keywords and medical subject headings (MeSH) terms. These terms, respectively, included (a) "Portulaca," "Portulaca oleracea," and "Purslane"; and (b)
"lipid," "lipoprotein," "hyperlipidemia," "dyslipidemia," "triacylglycerol,"
"triglyceride," "total cholesterol," "LDL-cholesterol," "HDL-cholesterol," "glycemic," "glycemia," "fasting blood glucose," "FBG," "fasting blood sugar," "FBS," "diabetes," and "diabetic". To increase the search sensitivity, quotation marks, parentheses, and asterisks were applied to search for the exact terms or expressions, locating a group of search terms and all of the words derived from one keyword, respectively.
Finally, the reference lists of selected studies and earlier reviews were manually screened to acquire other applicable publications.
| Study selection
The database search and the selection process of eligible papers were both performed by two independent scholars (A. H. and M. P.). All identified records were collected, and duplicate articles were removed.
Then, in order to select appropriate RCTs, titles and summaries of the remaining articles were screened, and in cases in which clear information was not presented, the full texts were retrieved and assessed.
Studies were included if they were human RCT that investigated the effects of purslane seed or extract on plasma/serum lipid and/or glucose concentrations. The following exclusion criteria were applied:
(a) studies with lack of adequate information required for meta-analy- Table 1 .
| Data extraction and quality assessment
Study characteristics and relevant results of selected RCTs were independently extracted by two researchers (A. H. and A. N.), using a standardized data extraction form. Extracted characteristics included publication information (name of first author, year, and location), study setting (RCT design, total sample size, intervention period, daily dose, and type of purslane and placebo), participant characteristics (health status, gender, mean age, and mean body mass index of subjects), and main outcomes, including total cholesterol (TC), triacylglycerol (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and fasting blood glucose (FBG). Two assessors (A. H. and M. P.) appraised the methodological quality of each study independently using the Jadad tool (Jadad et al., 1996) , which is a validated five-item scale used to assess the quality of RCT studies in a meta-analysis. This 5-point scale categorizes studies as high quality (>3 score), moderate (3 score), and low quality (<3 score) on the basis of criteria pertaining to randomization (0-2 points), blinding (0-2 points), and withdrawal or drop-out rate (1 point). Differences in the quality assessment process were settled by discussion. If necessary, arbitration was provided by the senior investigator (M. K).
| Statistical analysis
Quantitative synthesis with meta-analysis was conducted using the (Higgins and Green, 2011) . Based on the heterogeneity between studies, a random effect or fixed model was applied in the meta-analysis (Higgins and Green, 2011; Dersimonian & Laird, 1986 ).
The statistical heterogeneity was appraised and quantified using a chi-square test and the I 2 statistic, respectively. In the presence of significant interstudy heterogeneity (I 2 value greater than 50% or P < 0.05; Higgins and Green, 2011) , subgroup analysis was performed to determine potential sources of heterogeneity. The stability of the overall results related to each variable was examined through sensitivity analyses by omitting the results of one study at a time (Sahebkar, 2013; Sahebkar & Henrotin, 2016; Serban et al., 2015) . For the purpose of the publication bias evaluation, Egger's linear regression test and Begg's rank-correlation methods were performed on our analysis (Egger, Smith, Schneider, & Minder, 1997; Sterne & Bradburn, 2001) . Effect sizes were presented as MD with 95% confidence intervals and P < 0.05 was defined as significant for all analyses.
| RESULTS
The study selection process and reasons for excluding articles are presented in Figure 1 . In brief, 1,043 potentially eligible articles were identified from the aforementioned electronic databases. After excluding duplicate titles/abstracts, a total of 717 abstracts remained, of which 704 were removed on the basis of article title and abstract screening. The full text of the 13 remaining articles were scrutinized, and seven studies were omitted due to being uncontrolled (n = 3), duplicate report (n = 2), performed in adolescents (n = 1), and having duration less than 1 week (n = 1). Finally, six RCTs were included in the quantitative analysis.
| Characteristics of included studies
A detailed description of the studies' characteristics is presented in Table 2 . Six RCTs comprising 352 subjects were included in the metaanalysis. Studies were conducted in Iran (Bedakhanian et al., 2017; Dehghan et al., 2016; Esmaillzadeh, Zakizadeh, Faghihimani, Gohari, & Jazayeri, 2015; Farzanegi, 2014; Najafabadi, Dehghani, Behradmanesh, & Najarzadeh, 2015) and Israel (Wainstein et al., 2016) . The types of purslane supplementation and daily dosages varied among studies.
Four studies administered purslane as a powder (Dehghan et al., 2016; Esmaillzadeh et al., 2015; Farzanegi, 2014; Najafabadi et al., 2015) , whereas two studies (Bedakhanian et al., 2017; Wainstein et al., 2016) used capsules. The amount of Purslane powder administration was 10 g in two studies Najafabadi et al., 2015) and 7.5 g in the other two studies (Dehghan et al., 2016; Farzanegi, 2014) . In the two studies in which purslane was applied in capsule form, the supplementation dosage were 0.6 mg (Bedakhanian et al., 2017) and 0.18 mg (Wainstein et al., 2016) daily. Two studies (Dehghan et al., 2016; Farzanegi, 2014) involved solely females, one study only males (Bedakhanian et al., 2017) , and the three remaining studies Najafabadi et al., 2015 study (Bedakhanian et al., 2017) had subjects with metabolic syndrome, and one (Najafabadi et al., 2015) included nonalcoholic fatty liver patients. Five trials (Bedakhanian et al., 2017; Dehghan et al., 2016; Farzanegi, 2014; Najafabadi et al., 2015; Wainstein et al., 2016 ) used a parallel RCT design, and one study used a cross-over methodology. The mean age (year) and body mass index (kg/m 2 ) of participants were nearly 55 years and 29.61, respectively.
The duration of intervention ranged from 5 to 16 weeks. All articles were published between 2014 and 2016. In five studies (Bedakhanian et al., 2017; Dehghan et al., 2016; Esmaillzadeh et al., 2015; Farzanegi, 2014; Wainstein et al., 2016) , TG, TC, LDL-C, and HDL-C were reported as outcomes. FBG was measured in all trials.
| Quality assessment
In all trials, participants were randomly assigned into intervention and control groups, and four studies described the methodology of random-sequence generation. The blinding of subjects and researcher was reported in three studies. The methodology of blinding was reported in one study. Participant withdrawal was low to zero in all studies. Four studies (Bedakhanian et al., 2017; Esmaillzadeh et al., 2015; Farzanegi, 2014; Najafabadi et al., 2015) obtained a score of 3 and were considered as being of moderate quality. Two studies (Dehghan et al., 2016; Wainstein et al., 2016 ) achieved a score of 4
and were judged to be of high quality. Table 3 ). Subgroup analysis based on gender did not reveal any significant reduction in subgroups with female, male, and both gender participants (Table 3) . (Table 3) .
| Effect of purslane supplementation on TC

| Effect of purslane supplementation on HDL-C
The meta-analysis showed strong evidence of an effect on HDL-C by purslane intake neither in overall effect size (0.61 mg/dl, 95% CI [−1.54, 2.77]; I 2 = 0%; Figure 2e ) nor in the subgroups based on dose of purslane and participant gender (Table 3) .
| Sensitivity analysis
Sensitivity analyses in which each individual study was excluded one by one did not show any substantial change in the overall results of TC and HDL-C. However, the results of the sensitivity analysis of LDL-C and TG suggested a sensitivity of the pooled effect size to the Wainstein et al. (2016) and Bedakhanian et al. (2017) studies. Similarly, the removal of Adelnia-Najafabadi et al. (Najafabadi et al., 2015) from the overall effect size of FBG led to a loss of significance.
| Publication bias
No evidence of publication bias was detected in FBG (Begg's test P = 0.85; Egger's test P = 0.49), TG (Begg's test P = 0.62; Egger's test P = 0.94), TC (Begg's test P = 0.32; Egger's test P = 0.15), and LDL-C (Begg's test P = 0.62; Egger's test P = 0.39). A potential publication bias was revealed by Egger's linear regression test in HDL-C (Egger's test P = 0.002); however, Begg's rank correlation test did not show any evidence of publication bias (Begg's test P = 0.14).
| DISCUSSION
The results of this systematic review and meta-analysis suggest that purslane supplementation can be beneficial in reducing serum concentrations of FBG and TG. Nevertheless, no significant effect of purslane was observed on TC, LDL-C, and HDL-C in overall effect size. Subgroup analysis showed that the favorable effect on FBG, TG, TC, and LDL-C was robust and significant in the subset in which the dose of purslane supplementation was >1.5 g/day. Also, purslane seemed to be more effective on females than males in regulating FBG, TC, and LDL-C concentrations. However, due to the small number of studies in each subgroup based on gender, the results should be interpreted with caution.
Although purslane was administrated as powder or capsule in included studies, it does not seem that these two types of purslane have substantial different effect. Wainstein et al. (2016) reported that each capsule contained 60 mg of purslane, which had been extracted from 750-mg dried purslane. In this study, two capsules per day was administrated (equal 150-mg/day dried purslane), which is far from those administered as purslane powder (7-10 g/day). So it is more likely that different dose of supplementation rather than type of purslane is caused of different effect on outcomes.
The purslane was more effective in the female participant subset.
The reason for this result is unclear. The notable observed effect in female subjects might be related with the phytostrol component and its synergic influence with female hormones (Acedo, Reyes, & Rodriguez, 2013; Varlamov, Bethea, & Roberts Jr, 2015) .
Although the usage of purslane in traditional medicine dates back to many years ago, the small number of studies that have investigated it and the exact mechanism through which it might affect glycemic status and lipid profiles are not yet well understood. Several mechanisms have been suggested that might explain its medical properties. The favorable effect of purslane could be attributed to its high amount of flavonoid concentrations (Hertog, Feskens, Kromhout, Hollman, & Katan, 1993; Xu, Yu, & Chen, 2006) . Several flavonoids were detected in purslane, including quercetin, kaempferol, myricetin, apigenin, luteolin, genistein, and genistin (Zhang, Chen, Ma, & Shi, 2007) . Furthermore, purslane has a high omega-3 fatty acids content, the benefits of which have previously been shown to lower TG (McKenney & Sica, 2007; Skulas-Ray et al., 2010) , TC, and LDL-C (Nestel, 2000) . Omega-3 can improve insulin function (Oh, 2010) , glucose tolerance, and lipid profiles (Lu et al., 2011; Samimi, Jamilian, Asemi, & Esmaillzadeh, 2015) . It ameliorates hyperlipidemia through an inhibitory effect on both the fatty acid synthase enzyme complex and acyltransferase (El-Sayed, 2011) .
Beta-sitosterol is another active purslane component, which has cholesterol-and LDL-lowering effects (Abumweis, Barake, & Jones, 2008; Ostlund Jr, 2004) . Besides these, Purslane can increase insulin secretion by closing the K+/ATP channels, inducing membrane depolarization, and stimulating Ca2+ penetration (Ryle, Barker, Gaines, Thomson, & Chakraborty, 1984) . Also, purslane can regulate glycemic status by enhancing glucagon-like peptide-1 levels (Heidarzadeh et al., 2013; Lim & Brubaker, 2006) . Glucagon-like peptide-1 has an insulinotropic activity in T2D and can increase insulin secretion by receptor stimulation and inducing glucose-dependent insulin secretion (Kim & Egan, 2008) .
The favorable effect of purslane is not limited to lipid and glycemic modulation. There is evidence from several studies that has shown that the seeds and leaves of purslane have several therapeutic effects, such as antiscorbutic, antipyretic, diuretic, antiasthma, anti-inflammatory, and antitussive properties (Daniel, 2006) . Furthermore, the potential antioxidant activity of purslane constituents can decrease lipid peroxidation via scavenging free radicals, as well as enhancing intracellular concentrations of glutathione. This action leads to reduction of oxidized LDL-C levels and improved insulin receptor activity (El-Sayed, 2011) .
Purslane is a well-tolerable natural product and is considered as a safe complementary treatment, which is frequently used in folk medicine (El-Sayed, 2011) . The studies included in the current meta-analysis did not report substantial adverse effects resulting from purslane consumption. There is a recommended optimal dosage of purslane consumption that suggests that purslane intake has no adverse effects up to 30 g/day (Reid, 1987) . The sole concern is related to the high level of oxalic acid concentrations, which can enhance the risk of kidney stones, especially in at-risk individuals, and should be consumed with caution (Palaniswamy, Bible, & McAvoy, 2004) . Also, oxalate acid may affect the absorption of some minerals, such as calcium and iron (Bataille & Fournier, 2001 ). However, like as many herbal remedies, it should be used with caution in specific conditions such as pregnancy duration or in the pediatric population (Izzo, Hoon-Kim, Radhakrishnan, & Williamson, 2016) .
To the best of our knowledge, the present systematic review and meta-analysis is the first to assess the effects of purslane supplementation on glycemic status and lipid profiles and provide a thorough synthesis of results from RCTs. However, the present study has some limitations, which should be considered when interpreting the overall findings. The number of eligible studies in the present meta-analysis was relatively small. Furthermore, the lack of adjustment for potential confounders in the analysis of outcomes could potentially influence the findings of the studies included. There are multiple studies regarding the associations between lipid profiles and physical activity (Durstine et al., 2001) , diet (Obarzanek et al., 2001) , and smoking (Kar et al., 2016) . Unfortunately, these variables were not assessed in most of the studies included. Therefore, the overall findings may be confounded by these parameters.
| CONCLUSION
This systematic review and meta-analysis suggested the efficacy of purslane in improving lipid parameters and glucose levels. This result indicated that purslane supplementation has promising implications for improving glycemic status and blood lipid concentrations, especially in diabetic subjects, which have abnormal glucose and lipid metabolism. Further high-quality studies with various durations and dosages are needed to confirm these results.
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